The challenges of scaling cell-based therapies demand innovative solutions that reduce variability and streamline processes. CliniMACS® Instruments offer automated and closed cell processing for autologous and allogeneic strategies. Our solutions deliver reliability and minimize hands-on time. Accelerate your cell and gene therapy journey with flexible tools and expert support tailored to your needs 👉 https://ow.ly/qHb450Uto02
Miltenyi Biotec
Biotechnologieforschung
Bergisch Gladbach, North Rhine-Westphalia 87.135 Follower:innen
Empowering discovery. Advancing therapy.
Info
For over 30 years, Miltenyi Biotec has been a major provider of products and services that drive biomedical research and boost cell and gene therapy. More than 4,700 employees in 23 countries combine excellence in research with innovative products to create cutting-edge solutions that make cancer and other disease history. Our expertise spans research areas including immunology, stem cell biology, neuroscience, and cancer, and clinical research areas like hematology, graft engineering, and apheresis. At Miltenyi Biotec, scientists, engineers, software developers and many other professionals work together to improve human health by providing smarter cellular technology solutions to researchers and clinicians worldwide.
- Website
-
http://www.miltenyibiotec.com
Externer Link zu Miltenyi Biotec
- Branche
- Biotechnologieforschung
- Größe
- 1.001–5.000 Beschäftigte
- Hauptsitz
- Bergisch Gladbach, North Rhine-Westphalia
- Art
- Privatunternehmen
- Gegründet
- 1989
- Spezialgebiete
- Immunology, Stem Cell Research, Cancer Research, Neuroscience, Cell Isolation, Cell Sorting, Sample Preparation, Tissue Dissociation, Cell Culture, Cytokines, Antibodies, Imaging Agents, Molecular Analysis, Clinical Applications, Basic Research und Translational Research
Orte
Beschäftigte von Miltenyi Biotec
Updates
-
The application period for the 2024 MACS® Imaging Grant program has concluded. We are honored that so many researchers shared their brilliant ideas with us on how spatial biology in 2D and/or 3D could advance their research and are very pleased to announce this year’s winners: Kacper Walentynowicz, PhD Memorial Sloan Kettering Cancer Center Sanjeev Ranade, PhD Sanford Burnham Prebys Join us in congratulating these outstanding researchers. Learn more about how they will apply data from the MACSima™ and UltraMicroscope Blaze™ Platforms in their research: https://ow.ly/eSPw50UtVac
-
-
Opportunistic infections often affect immunocompromised patients, and sometimes these infections can resist standard therapies. If you're curious about alternative options involving memory T cells, we invite you to explore our solutions: https://ow.ly/ASZA50UsCRB
-
-
Spatial biology has made some waves this year! 🌊🔬👩🔬 Nature published an article recognizing spatial proteomics as the Method of the Year! We're excited that the MACSima™ Platform isn't just a part of the spatial proteomics revolution, but that with the release of our RNAsky® Detection Probes, it is a platform for transcriptomics as well. What we look back on with the most joy from this year is connecting with customers and researchers and seeing all the incredible discoveries being brought to light with the multiomic MACSima Platform. Other highlights for us have been: 💻 Webinars led by happy MACSima customers 🤝 Hosting MACS® Imaging and Spatial Biology Days 🌎 Meeting you at conferences around the globe We look forward to next year and all the promising exploration that is happening with spatial proteomics and transcriptomics! Read the Nature article here: https://ow.ly/tFhg50UrQF7 #SpatialBiology #MACSima
-
-
The first-ever ESSB conference has kicked off in Berlin and we were excited to meet you at booth #1, where we explored together our microscopy solutions, including the UltraMicroscope Blaze™ and MACSima™ Platform. Thank you for joining our lunch symposium, where we unlocked new insights in colorectal cancer and reveal how spatial multiomics is transforming tumor biology. Let's continue shaping the future of personalized cancer therapy together! #ESSB #SpatialBiology #Immunotherapy
-
-
At Miltenyi Biotec, we’re passionate about unlocking the full potential of HSCs ❤️. Whether you’re exploring new therapeutic avenues or refining clinical practices, we offer the tools you need. From cutting-edge products to streamlined workflows tailored for HSC research, our resources empower scientists and clinicians alike. Dive into our comprehensive solutions and see how we can support your journey in advancing HSC applications: https://ow.ly/mHJi50UnlYp
-
-
Think our "carpool chat" video on #CGT analytics was easy to record? Sit in a car, go for a drive, relax and shoot the breeze, right? Think again! We filmed our colleague Aimee-Jayne Tyler taking Stuart Curbishley to the train station on his way to give a talk about the #digitization of analytics for cell and gene therapy. What appears to be a leisurely spin through Birmingham actually required patience with traffic, astute navigation, self-control to not lose the production team, and a lot of rolling down windows. See for yourselves! #MiltenyiBiotec #drivingCGT #bloopers adthera bio
-
That’s a wrap on #ASH24! What an incredible time we’ve had this year! From exploring the latest breakthroughs in hematology to hosting insightful conversations at our booth on advancing cell and gene therapy manufacturing, it’s been an unforgettable experience. We’re proud to support this amazing community of physicians and scientists with tools that drive innovation, commercialization, and point-of-care treatments. Can’t wait to connect again at #ASH25 next year! #MiltenyiBiotec #ASH2024 #CGT #cellandgenetherapy
-
-
Beyond deciphering the crosstalk of cells in tissues, spatial biology has applications for immunotherapy development. Check out this quick example! Find more details in our Nature paper: 📰 https://lnkd.in/d2UjM32 And dive into how spatial biology works with our handbook: 👉 https://lnkd.in/enYN9pkp #SpatialBiology #MACSima #MiltenyiBiotec
-
The development of cell therapies requires a harmonious integration of manufacturing and analysis to ensure efficiency, scalability, and regulatory compliance. Together, the CliniMACS Prodigy® Platform and MACSQuant® Analyzer 16 form the ultimate team, simplifying your path from research to market success. Meet the perfect match: https://ow.ly/fm7K50UlAzg
-